Generation of stable egfp-expressing ipsc line, CAT. No. BX-6021, QTY: 7; differentiation to spinal motor neurons from ipscs, CAT. No. BX-6100, QTY: 4; and shipping, CAT. No. SH-0500, QTY: 1.
Ended Purchase Order Awarded
- Contract number
- 75N95021P00227
- Awardee
-
Brainxell, Inc. UEI CFGFE23M73T7
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $130,500
Award facts
- Opportunity
-
- 75N95021Q00167 Solicitation number
- Contract value 100% obligated
- $130,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53711, USA
Award details come from SAM.gov/FPDS.
About this award
This contract award to Brainxell, Inc., a for-profit manufacturer of specialized human neuron cells, was made by the Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences. The $130,500.00 firm fixed-price purchase order includes the generation of a stable EGFP-expressing induced pluripotent stem cell (iPSC) line, differentiation of iPSCs into spinal motor neurons, and associated shipping services. This work supports neurological disease research and drug discovery efforts at the NIH. There was no set-aside designation for this contract award.
Quick answers
Who was awarded contract 75N95021P00227?
75N95021P00227 was awarded to Brainxell, Inc. by National Institute on Drug Abuse (National Institutes of Health) on May 11, 2021.
How much is contract 75N95021P00227 worth?
The government has obligated $130,500 on 75N95021P00227.
Which agency awarded contract 75N95021P00227?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021P00227, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95021P00227 competed?
The extent of competition for 75N95021P00227 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award